LYRICA

TOKYO & NEW YORK--(BUSINESS WIRE)--Jul 6, 2011 - Pfizer Japan announced today the top-line results for Lyrica (pregabalin) Study A0081208 – Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate Efficacy and ...

Pfizer Japan Inc. announces positive results for Lyrica in phase 3 study of patients with fibromyalgia.

Pfizer Inc. (NYSE:PFE) recently presented positive top-line data on its blockbuster drug, Lyrica. Pfizer said that Lyrica met the primary endpoint in a study that was being conducted in patients with chronic central neuropathic pain following ...


  Lyrica in WIKIPEDIA. See news on Wikipedia.org
  Lyrica IMAGES. See images related to topic from google images